Glycated albumin as a biomarker for diagnosis of diabetes mellitus: A systematic review and meta-analysis

Figure 1 Flow chart of article selection.

Figure 2 Risk of bias and applicability concerns summary: Review authors’ judgements about each domain for each included study.

Figure 3 Risk of bias and applicability concerns graph: Review authors’ judgements about each domain presented as percentages across included studies.

Figure 4 Forest plots of serum glycated albumin for diagnosis of gestational diabetes mellitus and non-gestational diabetes mellitus at different thresholds.

Figure 5 Summary receiver operating characteristic plot of plasma glycated albumin concentrations of non-gestational diabetes mellitus, using hierarchical summary receiver operating characteristic parameters. HSROC: Hierarchical summary receiver operator characteristic curve.

Figure 6 Forest plots of different cut-off values of plasma glycated albumin for diagnosis of non-gestational diabetes mellitus.

Figure 7 Summary receiver operating characteristic plot of plasma glycated albumin concentrations at 14. 0%, using hierarchical summary receiver operating characteristic parameters. HSROC: Hierarchical summary receiver operator characteristic curve.

Figure 8 Deek’s funnel plot of included non-gestational diabetes mellitus studies.